glp-1 manufacturing news today Drugmakers and CDMOs seize opportunity, invest in facilities Fmr. FDA Commissioner weighs in

Second, the compounding pharmacy industry, which profited from these peptides and seeks to again, seems to have a friend in Kennedy

Angiotensin-converting enzyme 2 and renal disease

Species-function relationships shape ecological properties of the human gut microbiome

Antimicrobial resistance: a growing serious threat for global public health

Regular follow-up appointments should be scheduled according to individual needs, typically every 3-6 months during the first year of GLP-1 therapy, with thyroid function testing as clinically indicated

Due to the number of therapeutic errors that have occurred with these medications, we recommend patients talk with a pharmacist or a health care provider about how to use the pen appropriately, Marshall said